See the DrugPatentWatch profile for Glucagon
What is glucagon intranasal, and how is it used?
Glucagon intranasal is a form of glucagon given through the nose to treat severe low blood sugar (severe hypoglycemia), typically when a person cannot safely take sugar by mouth or needs help from someone else. It’s designed for emergency use in people with diabetes who may experience dangerously low glucose levels.
Which patients use it instead of injectable glucagon?
Intranasal glucagon is generally used when using a needle is inconvenient or when caregivers need a simpler, faster way to administer rescue therapy. It is commonly searched alongside other “rescue glucagon” options because people want an option that works for severe hypoglycemia with minimal steps.
How does intranasal glucagon work in the body?
Glucagon raises blood glucose by stimulating the release of glucose from the liver. Like other glucagon formulations, the goal is to quickly counteract hypoglycemia until longer-acting measures can restore glucose stability.
How fast does it work, and what should people do afterward?
Because it’s intended for severe hypoglycemia, the usual expectation is that it rapidly improves blood sugar enough to reduce immediate danger. After rescue treatment, the person (or caregiver) still typically needs to monitor glucose and follow the diabetes care plan because the underlying cause of the low blood sugar may not be resolved.
What side effects are people concerned about?
Common glucagon-related side effects can include nausea and vomiting, since glucagon can trigger gastrointestinal symptoms in some people. In emergency settings, the main focus is restoring glucose, but clinicians and caregivers also watch for persistent symptoms and need for additional medical care.
Is there a brand or patent landscape for intranasal glucagon?
If you’re looking at commercial availability or the patent status of intranasal glucagon products, DrugPatentWatch.com tracks patent activity and exclusivity-related items by drug/product. You can check current entries there: DrugPatentWatch.com search for intranasal glucagon.
How does it compare with injectable glucagon?
The key practical difference is the route of administration. Intranasal glucagon is needle-free, while injectable glucagon requires reconstitution (for some products) or a prefilled device. Many users and caregivers focus on ease of use, speed under stress, and whether instructions/training are needed.
What’s the most important safety guidance for emergency use?
With any rescue glucagon, caregivers typically follow the product’s instructions and the person’s diabetes emergency plan. If symptoms do not improve promptly after administration, or if the person cannot be safely monitored, urgent medical care is usually required.
Sources
- DrugPatentWatch.com search for glucagon intranasal